160
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Microarray analysis of altered long non-coding RNA expression profile in liver cancer cells treated by ginsenoside Rh2

, , , , , & show all
Pages 742-753 | Received 28 Aug 2017, Accepted 14 Jun 2018, Published online: 04 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mina Homayoonfal, Zatollah Asemi & Bahman Yousefi. (2023) Targeting long non coding RNA by natural products: Implications for cancer therapy. Critical Reviews in Food Science and Nutrition 63:20, pages 4389-4417.
Read now

Articles from other publishers (10)

Muhammad Ajmal Shah, Syed Muhammad Abuzar, Kainat Ilyas, Irtaza Qadees, Momna Bilal, Rimsha Yousaf, Roaa Mohammed Tahir Kassim, Azhar Rasul, Uzma Saleem, Maria Silvana Alves, Haroon Khan, Renald Blundell & Philippe Jeandet. (2023) Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis. Chemico-Biological Interactions 382, pages 110634.
Crossref
Tamires Cunha Almeida, Janaína Brandão Seibert, Tatiane Roquete Amparo, Gustavo Henrique Bianco de Souza, Glenda Nicioli da Silva & Orlando David Henrique dos Santos. (2022) Modulation of Long Non-coding RNAs by Different Classes of Secondary Metabolites from Plants: A Mini-review on Antitumor Effects. Mini-Reviews in Medicinal Chemistry 22:9, pages 1232-1255.
Crossref
Li Liu, Huiyun Wang, Xiaoyun Chai, Qingguo Meng, Sheng Jiang & Fenglan Zhao. (2022) Advances in Biocatalytic Synthesis, Pharmacological Activities, Pharmaceutical Preparation and Metabolism of Ginsenoside Rh2. Mini-Reviews in Medicinal Chemistry 22:3, pages 437-448.
Crossref
Jae Eun Park, Hwee Won Ji, Hyeon Woo Kim, Minjae Baek, Sanghyun Jung & Sun Jung Kim. (2022) Ginsenoside Rh2 Regulates the CFAP20DC-AS1/MicroRNA-3614-3p/BBX and TNFAIP3 Axis to Induce Apoptosis in Breast Cancer Cells. The American Journal of Chinese Medicine 50:06, pages 1703-1717.
Crossref
Rama Rao Malla, Vasudevaraju Padmaraju, Rakshmitha Marni & Mohammad Amjad Kamal. (2021) Natural products: Potential targets of TME related long non-coding RNAs in lung cancer. Phytomedicine 93, pages 153782.
Crossref
Jae Eun Park, Hyeon Woo Kim, Sung Hwan Yun & Sun Jung Kim. (2021) Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation. Journal of Ginseng Research 45:6, pages 754-762.
Crossref
Shuai Bian, Yue Zhao, Fangyu Li, Shuyan Lu, Song Yang, Meichen Liu, Siming Wang, Daqing Zhao, Wei Zhang & Jiawen Wang. (2021) Knockdown of p62/sequestosome enhances ginsenoside Rh2-induced apoptosis in cervical cancer HeLa cells with no effect on autophagy. Bioscience, Biotechnology, and Biochemistry 85:5, pages 1097-1103.
Crossref
Yujin Jin, Diem Thi Ngoc Huynh, Thuy Le Lam Nguyen, Hyesu Jeon & Kyung-Sun Heo. (2020) Therapeutic effects of ginsenosides on breast cancer growth and metastasis. Archives of Pharmacal Research 43:8, pages 773-787.
Crossref
Huan Gao, Di Liang, Chenchen Li, Guoxing Xu, Mengnan Jiang, Heng Li, Jianyuan Yin & Yanqing Song. (2020) 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis. Biomedicine & Pharmacotherapy 124, pages 109891.
Crossref
Guodong Zhang, Lixiang He, Junhao Chen, Botao Xu & Zejun Mao. (2020) Ginsenoside Rh2 activates α‑catenin phosphorylation to inhibit lung cancer cell proliferation and invasion. Experimental and Therapeutic Medicine.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.